Weight Loss Medication: Mounjaro ®

Mounjaro ® (active ingredient tirzepatide) is a GLP-1 GIP medication which contains the active ingredient tirzepatide. It is a once-weekly injectable medication that is FDA approved for use in adults with type 2 diabetes to help improve blood sugar control. That said, many patients who take Mounjaro ® for diabetes also experience weight loss as a beneficial side effect.

Medications like Mounjaro ® are unique from older classes of weight loss medications (like those containing the active ingredient phentermine) and exclusive GLP-1 agonists, because they combine elements that stimulate BOTH native GLP-1 (glucagon-like peptide-1) AND GIP (glucose-dependent insulinotropic polypeptide) receptors in a single “peptide” (short protein) molecule. Because GLP-1 GIP medications activate two receptors at a time, they are called “dual-agonist” medications. These receptors stimulate hormones that control blood sugar levels and reduce appetite, triggering weight loss.

For more information, visit Mounjaro ® | Eli Lilly and Company .

Mounjaro ® (active ingredient tirzepatide) works to stimulate naturally occurring GLP-1 and GIP receptors in the body. Combination GLP-1 GIP medications are not stimulants nor habit forming, and produce a variety of unique benefits to promote weight loss, health, and well-being, including:

For more information, visit Mounjaro ® | Eli Lilly and Company .

Mounjaro ® (active ingredient tirzepatide) is FDA-approved for treatment of type II diabetes. JumpstartMD and your doctor can help determine if you are a good candidate for Mounjaro® depending on a number of factors, including your body mass index (BMI) and health history.*

For more information, visit Mounjaro ® | Eli Lilly and Company .

If you’re interested in trying Mounjaro ® (active ingredient tirzepatide) for weight management, it’s important to discuss that option with your JumpstartMD healthcare provider to see if it’s a good option for you. Your JumpstartMD clinician will consider your medical history, current medications, and other factors before making a recommendation.

For more information, visit Mounjaro ® | Eli Lilly and Company .

Average full-retail price of Mounjaro ® (active ingredient tirzepatide) currently sits at nearly $1,200 per month. Fortunately, the manufacturers of Mounjaro® have implemented a discounted savings program wherein patients may receive Mounjaro® for as little as $25 a month with the Mounjaro Savings Card . Depending on your insurance and eligibility criteria, our clinicians can help to facilitate that savings program through our pharmacy partners with one exception being members on governmental payors such as Medicare, Tricare, or the VA.

For more information, visit Savings & Resources | Mounjaro ® .

We are also able to offer other cost-effective options for members whose insurance does not cover a particular medication.

Like all medications, Mounjaro ® (active ingredient tirzepatide) can cause side effects. The most common are nausea, with less frequent occurrences of vomiting, constipation, or other gastrointestinal symptoms. Our clinicians can prescribe medication to manage these side effects, which typically subside on their own after a few days or weeks.

For more information, visit Mounjaro ® | Eli Lilly and Company .

Yes, you can take Mounjaro ® (active ingredient tirzepatide) even if you do not have type 2 diabetes. While Mounjaro® is commonly prescribed for managing type 2 diabetes, it can also be used as a weight loss medication for individuals without diabetes. However, it is essential to consult with a healthcare provider to determine if Mounjaro ® is appropriate for your specific health needs and weight loss goals. Your JumpstartMD clinician will consider your overall health, medical history, and potential benefits and risks before recommending Mounjaro ® .

If your insurance doesn’t cover a GLP-1 GIP dual-agonist, don’t worry! Our clinicians are experts in medical weight management and have a full range of medications they can prescribe to help you achieve and maintain your health and wellness goals. We are also able to offer other cost-effective options for members whose insurance does not cover a particular medication.

Yes, while Mounjaro ® (active ingredient tirzepatide) is a GLP-1 GIP dual-agonist that has rightfully garnered significant headlines based on its efficacy, there are other options , including options with the same or similar active ingredient, which can be prescribed and used in combination with the right individualized nutritional guidance and support.